about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTLiuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegansNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Frontiers in Alzheimer's disease therapeutics.Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer diseaseConstruction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR AssaySublethal RNA oxidation as a mechanism for neurodegenerative diseaseScorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity.Combination treatments in Alzheimer's disease: risks and benefits.Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.Oxidative damage to RNA in aging and neurodegenerative disorders.Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury.Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects.Therapeutics of Neurotransmitters in Alzheimer's Disease.Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.
P2860
Q26749755-8CC9214A-8DBB-49E7-B643-B8376BA18F0BQ28483117-1EC1767E-9D5F-474A-AF6C-5975A6C3EEAAQ33726019-5B1CF05B-6AD3-4AE2-BC9F-ABD59C587C4AQ35086876-07CD2A0D-0E37-4651-BCAB-2D95A3B12AD5Q35137888-36394249-07E7-47BC-914A-167881F1F3DBQ36910522-B4F1C37B-AB46-4E7E-AD23-48617C4F464AQ37083453-BB9334E8-F525-4484-957E-235A9B92D2F9Q37124409-3214152F-EE86-4321-8C8F-53B165C23DC6Q37737293-9FF31184-EFF9-44C2-8B4A-4021F965B558Q37900307-6E35954B-655E-49C1-877E-AFB6C10D1ACFQ38016374-283A4196-CFF2-446C-A500-C6D865ABCB8AQ44961537-9C4CFBC1-1506-4A06-9B90-E311774685DAQ47216965-87841398-D1F0-4401-B1BE-E6B689F9968FQ49672905-EAF4F06D-3AC0-41D0-87CD-BEF110551BB5Q55093166-00A3D6E7-2F30-4F03-AB30-15676B7C4A9E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Therapeutic options in Alzheimer's disease.
@ast
Therapeutic options in Alzheimer's disease.
@en
type
label
Therapeutic options in Alzheimer's disease.
@ast
Therapeutic options in Alzheimer's disease.
@en
prefLabel
Therapeutic options in Alzheimer's disease.
@ast
Therapeutic options in Alzheimer's disease.
@en
P2860
P50
P356
P1476
Therapeutic options in Alzheimer's disease.
@en
P2093
Akihiko Nunomura
P2860
P304
P356
10.1586/14737175.6.6.897
P577
2006-06-01T00:00:00Z